skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: All-trans retinoic acid protects against arsenic-induced uterine toxicity in female Sprague-Dawley rats

Journal Article · · Toxicology and Applied Pharmacology

Background and purpose: Arsenic exposure frequently leads to reproductive failures by disrupting the rat uterine histology, hormonal integrity and estrogen signaling components of the rat uterus, possibly by generating reactive oxygen species. All-trans retinoic acid (ATRA) was assessed as a prospective therapeutic agent for reversing reproductive disorders. Experimental approach: Rats exposed to arsenic for 28 days were allowed to either recover naturally or were treated simultaneously with ATRA for 28 days or treatment continued up to 56 days. Hematoxylin-eosin double staining was used to evaluate changes in the uterine histology. Serum gonadotropins and estradiol were assayed by ELISA. Expression of the estrogen receptor (ER{alpha}), an estrogen responsive gene vascular endothelial growth factor (VEGF), and cell cycle regulatory proteins, cyclin D1 and CDK4, was assessed by RT-PCR, immunohistochemistry and western blot analysis. Key results: ATRA ameliorated sodium arsenite-induced decrease in circulating estradiol and gonadotropin levels in a dose- and time-dependent manner, along with recovery of luminal epithelial cells and endometrial glands. Concomitant up regulation of ER{alpha}, VEGF, cyclin D1, CDK4 and Ki-67 was also observed to be more prominent for ATRA-treated rats as compared to the rats that were allowed to recover naturally for 56 days. Conclusions and implications: Collectively, the results reveal that ATRA reverses arsenic-induced disruption of the circulating levels of gonadotropins and estradiol, and degeneration of luminal epithelial cells and endometrial glands of the rat uterus, indicating resumption of their functional status. Since structural and functional maintenance of the pubertal uterus is under the influence of estradiol, ATRA consequently up regulated the estrogen receptor and resumed cellular proliferation, possibly by an antioxidant therapeutic approach against arsenic toxicity. Highlights: Black-Right-Pointing-Pointer Arsenic disrupts the uterine histology and estrogen signaling components in rats. Black-Right-Pointing-Pointer Decrease in estradiol and gonadotropin levels, ER{alpha}, VEGF and cell cycle proteins. Black-Right-Pointing-Pointer Arsenic disrupts the above components by inhibiting antioxidant defense mechanism. Black-Right-Pointing-Pointer ATRA treatment led to recovery of uterine histology and ER{alpha} signaling components. Black-Right-Pointing-Pointer Vitamin A in diet is a promising cure for arsenic-induced reproductive failures.

OSTI ID:
22212571
Journal Information:
Toxicology and Applied Pharmacology, Vol. 257, Issue 2; Other Information: Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

Generation of ER{alpha}-floxed and knockout mice using the Cre/LoxP system
Journal Article · Fri Aug 10 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:22212571

Upregulation of estrogen receptor expression in the uterus of ovariectomized B6C3F1 mice and Ishikawa cells treated with bromoethane
Journal Article · Thu Dec 15 00:00:00 EST 2005 · Toxicology and Applied Pharmacology · OSTI ID:22212571

Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells
Journal Article · Fri May 11 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:22212571